P8IP
Pier 88 Investment Partners Portfolio holdings
AUM
$538M
This Quarter Return
+3.77%
1 Year Return
+9.78%
3 Year Return
+26.16%
5 Year Return
+53.5%
10 Year Return
–
AUM
$407M
AUM Growth
+$407M
(+2.4%)
Cap. Flow
-$6.26M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
52.21%
Holding
113
New
15
Increased
22
Reduced
26
Closed
8
Top Buys
| 1 |
Freshpet
FRPT
|
$2.96M |
| 2 |
Exxon Mobil
XOM
|
$2.14M |
| 3 |
NVIDIA
NVDA
|
$2.11M |
| 4 |
Boston Scientific
BSX
|
$1.97M |
| 5 |
KKR & Co
KKR
|
$1.87M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$4.17M |
| 2 |
Cloudflare
NET
|
$3.38M |
| 3 |
Datadog
DDOG
|
$2.5M |
| 4 |
EQT Corp
EQT
|
$1.89M |
| 5 |
ATI
ATI
|
$1.83M |
Sector Composition
| 1 | Technology | 5.54% |
| 2 | Industrials | 2.25% |
| 3 | Healthcare | 2.08% |
| 4 | Consumer Discretionary | 1.87% |
| 5 | Financials | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Schrodinger
SDGR
$1.4B
| $412K | 0.1% |
+15,260
| New | +$412K |
|
|
MODN
52
DELISTED
MODEL N, INC.
MODN
| $379K | 0.09% |
13,299
-550
| -4% | -$15.7K |
|
|
53
Mercado Libre
MELI
$121B
| $363K | 0.09% |
240
-2,760
| -92% | -$4.17M |
|
54
Tyler Technologies
TYL
$23.9B
| $361K | 0.09% |
850
-60
| -7% | -$25.5K |
|
|
55
Datadog
DDOG
$46.4B
| $358K | 0.09% |
2,900
-20,220
| -87% | -$2.5M |
|
56
ITT
ITT
$13.1B
| $354K | 0.09% |
+2,600
| New | +$354K |
|
57
Iovance Biotherapeutics
IOVA
$796M
| $339K | 0.08% |
22,900
-4,390
| -16% | -$65.1K |
|
58
Xylem
XYL
$34B
| $330K | 0.08% |
2,550
| – | – |
|
59
DTE Energy
DTE
$28.1B
| $325K | 0.08% |
2,894
| – | – |
|
60
Health Catalyst
HCAT
$238M
| $279K | 0.07% |
37,050
+7,950
| +27% | +$59.9K |
|
61
Helen of Troy
HELE
$556M
| $267K | 0.07% |
2,315
| – | – |
|
62
10x Genomics
TXG
$1.64B
| $266K | 0.07% |
7,100
+2,410
| +51% | +$90.4K |
|
63
SPDR S&P 500 ETF Trust
SPY
$649B
| $262K | 0.06% |
500
-400
| -44% | -$209K |
|
64
Absci
ABSI
$351M
| $247K | 0.06% |
+43,570
| New | +$247K |
|
65
Shift4
FOUR
$6.1B
| $235K | 0.06% |
+3,550
| New | +$235K |
|
66
Pyxis Oncology
PYXS
$80M
| $219K | 0.05% |
+51,360
| New | +$219K |
|
67
Dominion Energy
D
$50.5B
| $212K | 0.05% |
4,315
| – | – |
|
68
Krystal Biotech
KRYS
$4.25B
| $208K | 0.05% |
1,170
| – | – |
|
69
Neurocrine Biosciences
NBIX
$14B
| $200K | 0.05% |
+1,450
| New | +$200K |
|
70
BioMarin Pharmaceuticals
BMRN
$11.3B
| $161K | 0.04% |
1,840
+70
| +4% | +$6.11K |
|
71
Keysight
KEYS
$27.6B
| $159K | 0.04% |
1,015
-2,860
| -74% | -$447K |
|
72
AbCellera Biologics
ABCL
$1.23B
| $158K | 0.04% |
+34,980
| New | +$158K |
|
|
73
ATI
ATI
$10.7B
| $128K | 0.03% |
2,500
-35,820
| -93% | -$1.83M |
|
74
Doximity
DOCS
$12.5B
| $120K | 0.03% |
4,460
| – | – |
|
75
Equinox Gold
EQX
$7.16B
| $120K | 0.03% |
19,900
-1,985
| -9% | -$12K |
|